Alimetry has raised an oversubscribed US $18m A2 financing round to commercialize its wearable gut health monitoring device, capitalizing on increased adoption by a growing cohort of US hospitals. This adoption is driven by Alimetry receiving its fourth FDA clearance, the establishment of a CPT III reimbursement code, and the completion of over 30 clinical studies. Alimetry’s flagship AI powered product delivers accurate analysis and diagnosis of gut disorders that have been proven difficult to solve using conventional diagnostics and testing. The oversubscribed round was led by GD1 (Global from Day One), with participation from the American Gastroenterological Association (AGA) GI Opportunity Fund, Olympus Innovation Ventures, IceHouse Ventures, and follow on from existing investors. left to right: Dr. Armen Gharibans (Co-Founder, Alimetry), Vignesh Kumar (GD1 Co-Managing Partner), Dr. Greg O’Grady (Co-Founder, Alimetry). Nearly one in 10 people suffer from chronic gut symptoms ranging from abdominal pain to chronic indigestion, nausea and vomiting. The current diagnostic journey is slow and poor for patients, causing them to suffer through this period with a reduced quality of life. Alimetry is reducing the cost, time, and complexity of gut health diagnostics by providing rapid, upfront clarity and diagnosis that allows more effective and definitive treatment.
“Alimetry was designed to introduce clarity into a field that has involved lengthy, uncertain diagnostic journeys. It gives clinicians the tools they need to quickly and correctly diagnose patients so that we can move on from trial and error – and guesswork – into clarity of care and personalized medicine,” explains Alimetry chief executive Dr. Greg O’Grady, who is also a Professor of Surgery at the University of Auckland.
“Alimery turns months or even years of testing into improved clarity and safer, more accessible, less invasive care. They’ve demonstrated the power of technology to usher in a new era of tech-enabled diagnostics – in this case the undeniable connection of gut health to patient health,” comments Vignesh Kumar, GD1 Co-Managing Partner. How it works
Like the heart, the gut produces electrical current but these are 100 times weaker than the heart. Alimetry’s highly sensitive wearable device detects these […]
Alimetry secures $18 million to advance wearable gut health monitoring
